Skip to content
Research/Exosome Therapies/Exosome Scalp Microneedling

Exosome Scalp Microneedling

Exosome therapy for hair growth support. Therapy administered via scalp microneedling.

Intelligence Profile

Safety Profile

Safety Profile of Exosome Scalp Microneedling

Evidence Limitation Warning: The safety data for exosome scalp microneedling is extremely limited. While several clinical trials are listed as active or completed, detailed safety outcomes and adverse event profiles are not provided in the available evidence.

Known Side Effects

Based on the limited available evidence, specific side effects of exosome scalp microneedling have not been comprehensively documented. The evidence does not provide detailed adverse event data from the completed or ongoing clinical trials.

Potential microneedling-related effects (based on general microneedling procedures) may include:

  • Temporary scalp irritation
  • Mild bleeding or pinpoint bleeding
  • Temporary redness
  • Scalp sensitivity

Note: Exosome-specific adverse effects remain poorly characterized in the available literature.

Contraindications

No specific contraindications for exosome scalp microneedling are established in the provided evidence. This represents a significant knowledge gap that requires further research.

Drug Interactions

The available evidence does not provide information about potential drug interactions with exosome therapy or exosome scalp microneedling procedures.

Populations That Should Exercise Caution

The evidence does not specify which populations should avoid this treatment. However, given the investigational nature of exosome therapy, particular caution may be warranted for:

  • Pregnant or breastfeeding women
  • Individuals with active scalp infections
  • Patients with bleeding disorders
  • Those with compromised immune systems

Critical Evidence Gap: The provided studies do not include comprehensive safety data, contraindication profiles, or population-specific warnings.

Important Safety Considerations

Several clinical trials are currently active or recruiting (NCT06999408, NCT07221773, NCT07373054), suggesting this therapy is still being evaluated for both efficacy and safety. The completion of trial NCT06571799 indicates some safety data may exist but is not available in the current evidence base.

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical consultation. Patients considering exosome scalp microneedling should discuss potential risks and benefits with a qualified healthcare provider, particularly given the limited safety data available for this emerging treatment approach.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.